Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing darbepoetin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 25mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 40mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 60mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 100mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 200mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 150micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 100micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 80micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 60micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 50micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 40micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 30micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 20micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 15micrograms/0.375mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 10micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 15micrograms/0.375mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 20micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 30micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 40micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 50micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 60micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 80micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 100micrograms/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 150micrograms/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 10micrograms/0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 300micrograms/0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa + albumin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa + polysorbate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Darbepoetin alfa 500mcg injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only darbepoetin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only darbepoetin alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 100 microgram/mL solution for injection |
Has precise active ingredient |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 100 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 40 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 40 microgram/mL solution for injection |
Has precise active ingredient |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely darbepoetin alfa 25 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely darbepoetin alfa 25 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 200 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Darbepoetin alfa 200 microgram/mL solution for injection |
Has precise active ingredient |
True |
Darbepoetin alfa |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |